Mosquito-borne diseases are major health problems worldwide. Serological responses to mosquito saliva proteins may be useful in estimating individual exposure to bites from mosquitoes transmitting these diseases. However, the relationships between the levels of these IgG responses and mosquito density as well as IgG response specificity at the genus and/or species level need to be clarified prior to develop new immunological markers to assess human/vector contact. To this end, a kinetic study of antibody levels against several mosquito salivary gland extracts from southeastern French individuals living in three areas with distinct ecological environments and, by implication, distinct Aedes caspius mosquito densities were compared using ELISA. A positive association was observed between the average levels of IgG responses against Ae. caspius salivary gland extracts and spatial Ae. caspius densities. Additionally, the average level of IgG responses increased significantly during the peak exposure to Ae. caspius at each site and returned to baseline four months later, suggesting short-lived IgG responses. The species-specificity of IgG antibody responses was determined by testing antibody responses to salivary gland extracts from Cx. pipiens, a mosquito that is present at these three sites at different density levels, and from two other Aedes species not present in the study area (Ae. aegypti and Ae. albopictus). The IgG responses observed against these mosquito salivary gland extracts contrasted with those observed against Ae. caspius salivary gland extracts, supporting the existence of species-specific serological responses. By considering different populations and densities of mosquitoes linked to environmental factors, this study shows, for the first time, that specific IgG antibody responses against Ae. caspius salivary gland extracts may be related to the seasonal and geographical variations in Ae. caspius density. Characterisation of such immunological-markers may allow the evaluation of the effectiveness of vector-control strategies or estimation of the risk of vector-borne disease transmission.
Citation: Fontaine A, Pascual A, Orlandi-Pradines E, Diouf I, Remoué F, Pagès F, et al. (2011) Relationship between Exposure to Vector Bites and Antibody Responses to Mosquito Salivary Gland Extracts. PLoS ONE 6(12): e29107. https://doi.org/10.1371/journal.pone.0029107
Editor: Nicolas Fasel, University of Lausanne, Switzerland
Received: August 17, 2011; Accepted: November 21, 2011; Published: December 14, 2011
Copyright: © 2011 Fontaine et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported by the French Armed Forces Medical Service and the Délégation Générale pour l'Armement (DGA, SALIVAPULS project, Grant 07CO406 and ARTHROSER project, Grant 10CO401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Mosquito-borne diseases are a major health problem worldwide, and cause important morbidity and mortality in tropical areas , . To a lesser extend, the European population is also exposed to a variety of mosquito-borne pathogens. Outbreaks of mosquito-borne diseases with significant human health implications occurred on a mass scale in Europe in the last century. These outbreaks included the following: Dengue virus in Greece in 1928 , West Nile virus in Camargue in 1962  and in Romania in 1996 , Sindbis virus in Finland in 2002  and more recently, Chikungunya virus in Italy .
Numerous indexes can provide a comprehensive understanding of the potential for mosquito-borne disease transmission and the dynamics of these diseases in human populations, such as the vectorial capacity, the basic reproductive rate (R0) and the entomological inoculation rate (EIR) , . These indicators of disease transmission levels can also quantify the impact of vector-control strategies . These indexes mainly depend on entomological parameters that can be measured in the field, including the human-biting rate (HBR) (average number of bites per individual per day received from a mosquito species) . This parameter is currently estimated by entomological methods, such as human landing catches, or other strategies based on attractant traps (e.g., light traps, carbon-dioxide traps, odour-baited traps) . These entomological methods have proven efficacy for monitoring the density of mosquitoes relative to the density of the human population – but the HBR has been shown to vary within small geographic areas , , meaning that the results of local catches cannot be extrapolated to larger areas. These methods are not adapted to consider differences found within a population, which include differential attractiveness to mosquitoes  or other environmental and socioeconomic factors that could induce important variations in individual exposure to vector bites. Moreover, entomological methods can be labour intensive, expensive and difficult to implement when mosquito numbers are low or because of logistical constraints. In addition, the deliberate exposure of human volunteers to vectors has raised some ethical issues related to human landing catches, which remains the most reliable method to estimate host/vector contacts .
The use of immunologically based techniques to estimate individual exposure to arthropod vector bites, such as those from mosquitoes, ticks, sand flies and Glossina, has been described in several studies –. The saliva of hematophagous arthropods contains a complex mixture of biologically active proteins. These proteins may modify hemostatic responses and induce both cellular immunity and the production of specific antibodies , . As described previously, mosquito salivary gland extracts can induce an IgG antibody response in individuals living in endemic areas – and in travellers transiently exposed to vectors in tropical areas , suggesting that salivary proteins can potentially be used as immunological markers to evaluate individual exposure to mosquito bites.
Mosquito densities and species diversity can be influenced by the surrounding landscape, even in restricted areas , . The Mediterranean coast of southern France presents areas with distinct demographic and ecological conditions, ranging from large wetland areas in the Rhone River delta (Camargue) to highly urbanised environments (city of Marseille). These contrasting landscapes mirror the density and geographical spread of some mosquito species, notably Aedes caspius.
Ae. caspius is a Paleartic species that has demonstrated the ability to transmit the Rift Valley fever virus and the Chikungunya virus in the laboratory , . This mosquito species was also suspected to be involved in the 1993 Rift Valley fever outbreak in Egypt . Despite its low vector competence for these viruses, Ae. caspius should be considered a potential vector in wetland areas due to its high anthropophily and its abundance. Aedes caspius is well adapted to swampy environments: it tolerates varying levels of salinity in larval breeding sites, and its larval development is linked to the alternating dry and wet seasons in areas where its eggs are laid . After abundant rainfalls events, a massive, synchronous adult population emerges and becomes a nuisance . In Camargue, Ae. caspius is active from March to November , . Ae. aegypti and Ae. albopictus mosquitoes, both vectors of arboviruses (e.g., yellow fever, dengue or chikungunya viruses), were not endemic in the study area at the time of the present work .
To assess whether exposure to different densities and/or species of mosquitoes throughout the year could influence the antibody response against mosquito salivary gland extracts, we tested the IgG response to Ae. caspius salivary gland extracts of individuals living in three southern French areas (Camargue, Fos-sur-mer and Marseille) with distinct ecological environments at three time points (February 2007, September 2007 and January 2008). We concomitantly evaluated the IgG responses to salivary gland extracts from Culex pipiens, Aedes albopictus and Aedes aegypti as controls. The temporal and spatial evolution of IgG responses according to mosquito species will be discussed.
Kinetics of IgG antibody responses against Ae. caspius salivary gland extracts (AecSGE) from individuals living in distinct ecological environments
First, we determined whether mosquito density, linked to the ecological environment and season, could influence the IgG responses against mosquito salivary gland extracts. Thus, the IgG responses against AecSGE were assessed in individuals living in Camargue, Fos-sur-mer or Marseille (Figure 1) at three time points: February 2007 (T1) and January 2008 (T3), which corresponded to periods outside of the Ae. caspius exposure peak, and September 2007 (T2), which corresponded to the Ae. caspius exposure peak period . Independent of the sampling time (i.e., T1, T2 or T3), the IgG antibody responses against AecSGE were significantly different among the sites (Kruskal-Wallis test, p<0.0001, Table S1). Additionally, independent of the site, the IgG response against AecSGE increased significantly from T1 to T2 (Figure 2A, Wilcoxon matched pairs test, p<0.0001, p<0.0018 and p<0.0001 for the Camargue, Fos-sur-mer and Marseille sites, respectively, Table S1) and decreased significantly from T2 to T3 (Wilcoxon matched pairs test, p<0.0001 for the three sites). These variations gradually decreased in individuals living at the Camargue site (i.e., the mean change in ΔT2-T1OD was +0.26, with a 95% confident interval (95% CI) from +0.14 to 0.38) compared to those living in the city of Marseille (i.e., +0.05 [0.01 to 0.09]), with intermediate variation observed for those living in Fos-sur-mer (i.e., +0.13 [0.07 to 0.18]). The mean changes in ΔT2-T1OD between the Camargue and Fos-sur-mer as well as the Camargue and Marseille sites were significantly different (p = 0.019 and p<0.0001, respectively, Mann-Whitney test). No significant differences (Mann-Whitney test, ns) were observed when comparing the mean change in ΔT2-T1OD between the Fos-sur-mer and Marseille sites. In contrast, outside of the period of peak exposure to mosquito bites (i.e., T1 and T3) at the three sites, the antibody response against AecSGE returned to the background level at each site (Camargue, +0.04 [−0.06 to 0.14]; Fos-sur-mer, +0.09 [−0.13 to −0.04]; Marseille, +0.01 [−0.02 to 0.04]). Variations in the IgG antibody responses detected between T3 and T1 were considered not to differ (mean ΔT3-T1OD <0.1). The cut-off value for seropositivity (mean aOD ±3 standard deviation) was defined as 1.03 based on the IgG reactivity of sera from individuals living in Marseille who were not exposed to Ae. caspius. Individuals showing aOD values above this cut-off level were classified seropositive. Seroprevalence significantly increased among individuals living at the Camargue study site from the T1 time point to the end of the exposure peak (T2), with values increasing from 29% to 54% (chi-squared test, p<0.0249, Figure 2B). In addition, seroprevalence significantly declined after the exposure peak and returned to the baseline level (T3 = 29%, chi-squared test, p<0.0249). Although an increase in seroprevalence was observed from T1 to T2 and a decrease was observed from T2 to T3 for individuals living at the Fos-sur-mer study site, these variations were not significant (chi-squared test, Figure 2B). No significant change in seroprevalence was observed between T1 and T3 at the Fos-sur-mer and Camargue sites. Additionally, no significant differences were observed when comparing seroprevalence between the two study sites independently of the sampling time (chi-squared test).
The city of Marseille and the town of Fos-sur-mer are indicated by circles, and the Camargue area is cross-hatched.
(A) IgG serum levels against Ae. caspius salivary gland protein extracts. Scatter plots of IgG antibody responses against Ae. caspius salivary gland extracts in individuals from Marseille (squares), Fos-sur-mer (circles) and Camargue (triangles) at three times February 07 (T1), September 07 (T2) and January 08 (T3), are presented with the sampling time indicated in white, grey and black symbols, respectively. Antibody responses are represented by aOD: the mean OD value of wells with antigen minus the mean OD value of wells without antigen. Each point shows the aOD value for a single individual. Horizontal bars show medians. Differences between the two time points at a single site were tested using the Wilcoxon signed-rank test. p-values are indicated. (B) Seasonal variation of seroprevalence against Ae. caspius salivary gland protein extracts at the three study sites. Seroprevalence against Ae. caspius salivary gland extracts in individuals from Fos-sur-mer and Camargue at three times February 07 (T1, white bars), September 07 (T2, light grey bars) and January 08 (T3, dark grey bars) are represented. Whiskers indicate the 95% confidence interval. The p values were determined by the chi-squared test.
Kinetics of IgG antibody responses to Cx. pipiens salivary gland extracts (CxpSGE) in individuals living in distinct ecological environments
The IgG responses to CxpSGE were assessed using the same sera as that used for the AecSGE assay. High inter-individual heterogeneity in the antibody responses was observed at all time points and for all sites (Figure 3). Independent of the sampling time (i.e., T1, T2 or T3), no significant difference was observed in the IgG antibody responses to CxpSGE between the sites (Kruskal-Wallis test, Table S1). With respect to the kinetics, despite statistically significant variation being detected in the IgG antibody response to CxpSGE between the T2 and T3 time points for the Camargue and Fos-sur-mer sites (Wilcoxon matched pairs test, p<0.0001 and p = 0.0028 for the Camargue and Fos-sur-mer sites, respectively, Table S1), these variations were weak. The IgG antibody variations for the Camargue and Fos-sur-mer sites were considered not to differ (below than 0.1 ΔOD), indicating global stability of IgG responses to CxpSGE throughout the year. Conversely, in the city of Marseille, the variations in the IgG responses observed from T1 to T2 and T2 to T3 were significant (Wilcoxon matched pairs test, p = 0.016/74 and p<0.0001 for ΔT2-T1OD and ΔT3-T2OD, respectively) and relevant (ΔT2-T1OD +0.1 [0.01 to 0.19]; ΔT3-T2OD −0.15 [−0.21 to 0.08]).
Scatter plots of IgG antibody responses against Cx. pipiens salivary gland extracts in individuals from Marseille (squares), Fos-sur-mer (circles) and Camargue (triangles) at three times, February 07 (T1), September 07 (T2) and January 08 (T3), are represented in white, grey and black symbols, respectively. Antibody responses are represented by aOD: the mean OD value of wells with antigen minus the mean OD value of wells without antigen. Each point shows the aOD value for a single individual. Horizontal bars show medians. Differences between two sampling times at a single site were tested using the Wilcoxon signed-rank test. p-values are indicated.
Kinetics of antibody responses to Ae. albopictus (AealSGE) and Ae. aegypti salivary gland extracts (AeaeSGE) in individuals living in distinct ecological environments
To estimate the specificity of the IgG response to AecSGE, the same sera were assessed for IgGs against salivary gland extracts of two mosquitoes from the Aedes genus (i.e., Ae. albopictus and Ae. aegypti) that were not endemic in the study area until 2008 (Figure 4) . Independent of the sampling time (i.e., T1, T2 or T3), no significant difference was observed when the IgG antibody responses to AealSGE or AeaeSGE were compared between sites (Kruskal-Wallis test, Table S1). With regard to the kinetics analysis, despite statistically significant variations being detected in the IgG antibody response to AealSGE or AeaeSGE between some of the time points at the three sites, these variations were below 0.1 ΔOD and were considered to not differ.
Scatter plots of IgG antibody responses against the salivary gland extracts of Ae. aegypti (A) and Ae. albopictus (B) in individuals from Marseille (squares), Fos-sur-mer (circles) and Camargue (triangles) at three time points February 07 (T1), September 07 (T2) and January 08 (T3), are represented in white, grey and black symbols, respectively. Antibody responses are represented by aOD: the mean OD value of wells with antigen minus the OD value of wells without antigen. Each point shows the aOD value for a single individual. Horizontal bars show medians. Differences between two time points at a single site were tested using the Wilcoxon signed-rank test. p-values are indicated.
Correlation of the IgG response between mosquito species
To estimate the level of cross-reactivity of the IgG response to the salivary gland extracts between two mosquito species at T2 (September 2007) at the three sites, a Spearman's rank correlation coefficient (rho) test was used, and the corresponding p-values were determined (Table 1). Significant positive correlation coefficients (rho>0.42; p<0.0083) were obtained when the mosquitoes of the Aedes genus were compared at the three sites, mainly for IgG responses against non-prevalent mosquitoes (i.e., albopictus and aegypti). Conversely, no significant correlation was observed between the IgG responses against CxpSGE and those against the three other Aedes species at the three sites, except for the Fos-sur-mer site, where a significant positive correlation coefficient (rho = 0.43; p = 0.0079) was obtained when the IgG responses against CxpSGE and AecSGE were compared (Table 1).
Numerous studies have reported that mosquitoes' salivary components can induce an antibody response in humans under natural conditions , , , . Here, we analysed human antibody responses against AecSGE according to spatial (environment) and temporal (seasons) variations in the level of Ae. caspius mosquito exposure. The specificity of the IgG response was also estimated at the genus and species levels.
The Mediterranean coast of southern France includes areas with distinct demographic and ecological conditions that greatly influence the dispersion and composition of the mosquito fauna. Thus, three sites were selected in this area on the basis of environmental patterns influencing Ae. caspius density: the Camargue area, the town of Fos-sur-mer and the city of Marseille. In the Camargue wetlands, Ae. caspius is well adapted to the rural and swampy environment where it encounters favourable climatic and biotope conditions , . The city of Marseille presents an urban habitat that is more suitable for Cx. pipiens mosquitoes than rural mosquitoes, such as Ae. caspius , . Fos-sur-mer, a mid-sized town located between the Camargue area and Marseille, has an intermediary environment and is also exposed to Ae. caspius mosquitoes. To confirm the geographic distribution and the different densities of Ae. caspius among these three sites, collection of mosquitoes was conducted in July 2007 using carbon dioxide dry ice traps. The collected specimens indicated a decreasing mosquito density gradient from Camargue to Marseille. Cx. pipiens and Ae. caspius were the most abundant mosquitoes at Camargue (31% and 29%, respectively), as previously described , . Ae. caspius mosquitoes were captured at the Fos-sur-mer site (21%), but none were found in Marseille (Table S2). Thus, Camargue, Fos-sur-mer and Marseille were considered sites with high, medium and very low levels of exposure to Ae. caspius bites, respectively.
In the present study, we showed that the IgG antibody responses to AecSGE evolved in accordance with the Ae. caspius density, which is influenced by both seasonal changes and the ecological environment. The variations in the IgG antibody levels against AecSGE between the peak exposure at T2 and the T1 baseline level were approximately 2- and 4-fold higher in Camargue than in Fos-sur-mer and Marseille, respectively. This positive relationship between anti-salivary protein IgG levels and the seasonal variation of human exposure to mosquito bites has previously been reported , , , . Moreover, the average IgG response level against AecSGE observed at T3 returned to T1 baseline levels only four months after the exposure peak (T2), suggesting a short-lived IgG response. A decrease in the IgG response against salivary gland extracts after a period of non-exposure has been described for outdoor workers exposed to ticks  and for travellers transiently exposed to An. gambiae and Ae. aegypti mosquitoes . The transient anti-saliva IgG response and its relationship with mosquito density may be useful for assessing mosquito exposure and could thus, provide new immunological tools to evaluate anti-vector strategies or to monitor vector populations . Recently, Drame and colleagues have confirmed the potential of An. gambiae saliva for use as an immunological exposure marker to assess the risk of malaria transmission and the efficiency of antivectorial strategies in a malaria-endemic area .
It is worth pointing out that baseline IgG levels against AecSGE were significantly and pertinently higher at Camargue and Fos-sur-mer than at Marseille. Repeated seasonal exposure to Ae. caspius seemed to favour maintaining a high baseline IgG level throughout the year. To test this hypothesis, a comparison of the kinetics of the IgG response against AecSGE, collected outside the Ae. caspius exposure peak (cold season) between individuals who had lived for a long period (i.e., at least 5 years) in Camargue and newcomers could be performed. Further studies may also analyse the kinetics of the antibody response in children born in Camargue. Collectively, these data suggest that to determine the prevalence of seroreactivity against AecSGE, several parameters should be considered, including mosquito density and the environment, historical mosquito exposure (time spent in a particular area) and individual behaviour (e.g., outdoor/indoor activities, use of mosquito nets or repellents).
To evaluate the specificity of this IgG antibody response, the same sera were first tested against CxpSGE. The mosquito collection performed in July 2007 indicated that Cx. pipiens was present at all sites, with decreasing densities observed from Camargue to Marseille. In contrast to the IgG response observed to AecSGE, the IgG levels against CxpSGE were considered not to differ spatially and temporally, with the exception of the levels from Marseille. Individuals from Marseille presented a significant and pertinent increase in the IgG levels against CxpSGE after the peak of exposure. These results indicated that unlike the responses against Ae. caspius, the IgG responses against CxpSGE appeared to not be associated with the decreasing density of Cx. pipiens from Camargue to Marseille. This phenomenon could be attributed to a distinct Cx. pipiens behaviour that could occur between sites. The temperate species Culex pipiens Linné can effectively be divided into two different biological forms: Culex pipiens pipiens (Cx. p. pipiens) and Culex pipiens molestus (Cx. p. molestus) , . These two subspecies are relatively morphologically similar but exhibit different physiological and behavioural traits , . In contrast to the rural Cx. p. pipiens, the urban Cx. p. molestus is anthropophilic , breeds in underground urban habitats, is able to lay its first batch of eggs without a blood meal, does not hibernate and can mate in confined spaces , . In Camargue, Culex pipiens L. mosquitoes were found at a high density in bird-baited traps compared to horse or human baited-traps, suggesting that the non-anthropophilic form of Culex pipiens L. dominates in this rural area , . This species is a moderately efficient laboratory West Nile virus vector, but in southern France, it is considered to be a main vector in the dry areas and a secondary vector in the wetlands such as Camargue , . Although few entomological data are available for Marseille, the anthropophilic Cx. p. molestus form is very likely to occur there, which could represent an explanation for the pertinent IgG increase observed during the warm season. Nevertheless, continuous exposure or an insufficiently long period of non-exposure to Cx. pipiens bites throughout the year could limit the IgG baseline feedback, potentially explaining the moderate seasonal variations of IgG that have been observed , . Collectively, these data showed that IgG antibody responses against AecSGE and CxpSGE evolved differently according to site and season, suggesting a specificity of the serological response against AecSGE.
Cross-reactivity was evaluated using correlation tests between the IgG levels against AecSGE and CxpSGE at the exposure peak. Differences were detected in the results according to the location. For Camargue and Marseille, the absence of a significant correlation between the IgG levels against AecSGE and CxpSGE corresponded to the low antigen cross-reactivity between these two species, which belong to different genera. Conversely, for Fos-sur-mer, a significant positive correlation was detected between these two species. Because both species are present at this site, the correlation could be due more to dual exposure to Ae. caspius and Cx. pipiens than to antigen cross-reactivity. Thus, our results support a genus-specific IgG response.
It is of note that the IgG response heterogeneity (i.e., between individuals from the same area) observed for Cx. pipiens and, to a lesser extent, for Ae. caspius might reflect heterogeneous exposure to mosquito bites due to individual behaviours (e.g., outdoor/indoor activities, use of mosquito nets or repellents). Additionally, these two mosquito species exhibit distinct circadian biting activities (e.g., clearly diurnal and nocturnal biting activities are observed for Ae. caspius and Cx. pipiens mosquitoes, respectively) , which could further increase this inter-individual heterogeneity.
Finally, intra-genus specificity was estimated using SGE from two Aedes species that were not endemic at the three sites during the time of the study. The very low IgG levels observed against AealSGE and AeaeSGE, independent of the site and timing, indicated that the IgG responses to AecSGE were specific at the species level. Nevertheless, the significant correlation coefficients obtained when the levels of IgG against mosquitoes from the Aedes genus were compared suggest cross-reactivity. These correlations were not attributed to dual exposure (because these mosquitoes were not present in the study area), but to the presence of shared salivary antigens between different Aedes species .
Collectively, these data showed that the IgG antibody response against AecSGE may be related to seasonal and geographical variations in Ae. caspius density. The pertinent increase and transient IgG response at the peak of exposure appears to be species-specific, and these results strongly suggest that human antibody responses may be used to assess the individual level of exposure to mosquito bites. Nevertheless, other parameters should be considered, including historical individual exposure, which could influence the baseline IgG level. Further studies are needed to characterise specific AecSG antigens, for instance, using an immunoproteomic approach, as described previously –. This step of identifying the antigenic protein repertoire is necessary to determine the diversity and specificity of this repertoire. Salivary proteins of different arthropod species can share sequence similarities  and cross-reacting antigens , , resulting in the need to select species-specific antigens. Recombinant forms of selected salivary gland antigen candidates could be used for the development of a more sensitive and specific immunological test to accurately assess individual exposure to mosquito bites. Thus, specific immune responses against mosquito saliva antigens could be used in control and surveillance programs to assess the efficiency of anti-mosquito strategies, to estimate exposure levels and to identify new infestation areas. This strategy could be extended to other mosquito species that are involved in the transmission of infectious diseases and could represent a tool for estimating the risk of vector-borne disease transmission. Collectively, these data confirm that human antibody responses may be used to assess individual exposure to mosquito bites from particular species and estimate the level of these pests.
Materials and Methods
All participants gave their written informed consent to participate in the study, and the Marseille-2 Ethical Committee approved the protocol (N°2006-A00581-50). Mosquito larval sampling was carried out in non-privately owned areas and non-protected areas outside the boundaries of the regional nature park of Camargue. The field study did not involve endangered or protected species. No specific permissions were required for the described field studies.
The study was conducted in the Provence-Alpes-Côte d'Azur (PACA) area in southeastern France. Three study sites in PACA were chosen: (i) Camargue, a large wetland area of 150,000 hectares  located inside the Rhone River delta, principally covered with pools of water, marshes and irrigated fields, where the human population is distributed between towns, hamlets and isolated houses , ; (ii) Fos-sur-mer, a town with 14,000 inhabitants (population density, 151 inhabitants/km2) with a mixed residential and agricultural landscape, located approximately 15 km from the border of the Camargue area; and (iii) the city of Marseille, a dry, an urban area with approximately 852 400 inhabitants and located approximately 30 km from Fos-sur-mer (Figure 1).
Volunteers were recruited from Camargue (n = 41, 54% male, mean age ± SD: 45.7±11.3, Caucasian), Fos-sur-mer (n = 26, 42% male, mean age± SD: 51.5±11, Caucasian) and Marseille (n = 38, 47% male, mean age± SD: 40.3±12.2, Caucasian). For each individual, blood samples were collected by venous puncture at three different time points: February 2007, September 2007 and January 2008. Sera were obtained through centrifugation of the blood samples and were stored at −20°C. Eligible participants were individuals who did not travel to countries or areas that are endemic for Ae. aegypti and Ae. albopictus mosquitoes in the six months prior to and during the study –.
Mosquitoes and salivary gland extraction
Adult female Ae. caspius, Cx pipiens, Ae. aegytpi and Ae. albopictus mosquitoes were used in this study. Ae. caspius and Cx. pipiens species were collected at the larval stage in the field in Camargue from August to September 2009, and the mosquitoes were reared in an insectarium. The Ae. albopictus mosquito colony came from the Alpes-Maritimes area and was bred in a laboratory at the Entente Interdépartementale pour la Démoustication (EID) Méditerranée (Cagnes-sur-Mer). Ae. aegypti mosquitoes came from the Bora-Bora reference colony, which was bred in a laboratory at the Institut de Recherche pour le Développement (Montpellier). All of these mosquitoes were maintained under identical standard conditions of 26°C and 60% humidity. All mosquitoes consumed no blood meals and were maintained on a diet of a 10% syrup solution. Salivary glands from 5- to 8-day old adult female mosquitoes were dissected on ice in phosphate-buffered saline (PBS) under a stereomicroscope. The salivary glands were pooled by species in a microcentrifuge tube and were then stored frozen at −20°C until needed. At that time, the salivary glands were disrupted by ultrasonication (Vibracell 72412, Bioblock Scientific, Illkirch, France) for 5 min on ice at maximum amplitude. Salivary gland homogenates were then centrifuged for 15 min at 16,100× g  and the protein concentration of the supernatant was determined in duplicate by the Lowry method (DC Protein assay Kit, Bio-Rad) according to the manufacturer's instructions. Salivary gland proteins were then suspended in 0.1 M (pH 9.6) bicarbonate buffer to obtain a protein concentration of 1 µg/µL.
The sera were tested by ELISA for the presence of IgG antibodies that bind to salivary gland proteins. To optimise the working conditions of the ELISA tests, a checkerboard titration was performed to establish salivary gland protein extracts and serum conditions. Based on the results of this procedure, Maxisorp Microtiter Immunoplates (Nunc, Denmark) were coated with 2 µg/ml (50 µl/well) of either Ae. caspius, Cx. pipiens, Ae. albopictus or Ae. aegypti salivary gland extracts diluted in 0.1 M bicarbonate buffer (pH 9.6) overnight at 4°C. Three washes were performed with 250 µL of PBS (pH 7.4, Sigma Co., USA) plus 0.05% Tween-20 (Sigma Co., USA) between each incubation. The plates were blocked for 2 h at 37°C with 200 µL of blocking solution buffer consisting of PBS, 0.05% Tween and 5% skimmed milk (Beckton, Dickinson Bioscience, USA). Serum diluted 1∶50 in blocking buffer was added (50 µl/well) to the plates, and they were incubated at 37°C for 1 h . Subsequently, 50 µl of horse radish peroxidase (HRP)-conjugated rabbit anti-human IgG (1∶10,000, Invitrogen, Rockville, USA) diluted in the blocking buffer were added, followed by incubation for 1 h at 37°C. Enzyme activity was detected by incubation with 50 µl of tetramethylbenzidine substrate (KPL, USA) for 10 min at room temperature. The reaction was stopped using 50 µl of 1 M H2SO4. The optical density (OD) at 450 nm was determined with a microplate reader (Versa Max® Turnable Multiplate Reader, Molecular Devices, UK). Each serum sample was tested in duplicate and in control wells without salivary gland extracts. To improve the consistency of the results, sera from different study sites were randomly arranged on each plate, and the samples collected at different time points for each individual were tested on the same plate. A pool of 5 sera collected in September 2007 from individuals living in Camargue (selected based on ELISA optimisation tests) was used as a positive control on all plates coated with salivary gland extracts from Ae. caspius and Cx. Pipiens. A pool of 5 sera from individuals living in inter-tropical areas, kindly provided by Dr. F. Remoué, was used as a positive control against salivary gland extracts from Ae. aegypti  and Ae. albopictus. Only plates presenting inter-assay variations in absorbance values of positive controls lower than 20% were included in the analysis. The levels of IgG antibodies were expressed as the adjusted OD (aOD), which was calculated for each serum sample as the mean OD value for wells with salivary gland extracts minus the OD value of the control wells, i.e., without salivary gland extracts. Individual variations in IgG antibody responses were assessed according to the OD differences (ΔOD) between pairs of sera collected throughout the year. To consider pertinent ΔOD between pairs of sera, an arbitrary threshold of 0.1 ΔOD was defined . The mean aOD at the three time points for individuals not exposed to Ae. caspius living in Marseille plus 3 standard deviations was used as the cut-off value for seropositivity.
After verifying that the values in each group did not assume a Gaussian distribution, the Kruskal-Wallis, Mann-Whitney and Wilcoxon matched-pairs signed-rank tests and Spearman's rank correlation coefficient were computed when appropriate with STATA version 9.0 (Stata-Corp, USA). The frequencies were compared by the chi-squared test. All differences were considered significant at p<0.05. However, for multiple tests, a Bonferroni correction was applied and p-value significance was then indicated.
Statistical analysis of spatial and temporal variations in IgG responses. The Kruskal-Wallis tests were used to compare the antibody levels between more than two independent groups (geographical comparisons). Wilcoxon matched-pairs signed-rank tests were used to compare paired sera between two time points. All significant differences (p<0.05) are indicated in bold. SD: standard deviation, aOD: adjusted optical density, CI: confident interval, T1: February 07, T2: September 07, T3: January 08.
Adult mosquitoes captured at each site in July 2007 using carbon dioxide dry ice traps. Carbon dioxide traps were hung in 5 locations in each study site during 24 hrs. Mosquitoes were identified using morphological characteristics and identification keys. The mean number of mosquitoes sampled in each site was calculated using the results of the five traps. The proportion of each mosquito genus/species per site is indicated into brackets.
The authors gratefully acknowledge D. Fontenille, M.N. Lacroix from IRD UR016 and G. Lacour from EID Méditerranée for access to mosquitoes bred in the insectary and D. Caire, N. Bonton and G. l'Ambert (EID Méditerranée) for access to wild mosquito larvae in the Camargue area. The authors are indebted to S. Bourdon for technical support and F. Gardella and T. Coffinet who conducted the entomological survey. The authors also acknowledge all individuals for their participation.
Conceived and designed the experiments: LA CR EO-P TF FP. Performed the experiments: AF AP. Analyzed the data: AF LA CR. Contributed reagents/materials/analysis tools: ID FR. Wrote the paper: AF LA.
- 1. Gubler DJ (1998) Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 11: 480–496.
- 2. Tolle MA (2009) Mosquito-borne diseases. Curr Probl Pediatr Adolesc Health Care 39: 97–140.
- 3. Chastel C (2009) [Lessons from the Greek dengue epidemic of 1927–1928]. Bull Acad Natl Med 193: 485–493.
- 4. Mouchet J, Rageau J, Laumond C, Hannoun C, Beytout D, et al. (1970) [Epidemiology of West Nile virus: study of a focus in Camargue. V. The fector: Culex modestus Ficalbi Diptera; Culicidae]. Ann Inst Pasteur (Paris) 118: 839–855.
- 5. Campbell GL, Ceianu CS, Savage HM (2001) Epidemic West Nile encephalitis in Romania: waiting for history to repeat itself. Ann N Y Acad Sci 951: 94–101.
- 6. Kurkela S, Manni T, Myllynen J, Vaheri A, Vapalahti O (2005) Clinical and laboratory manifestations of Sindbis virus infection: prospective study, Finland, 2002–2003. J Infect Dis 191: 1820–1829.
- 7. Bonilauri P, Bellini R, Calzolari M, Angelini R, Venturi L, et al. (2008) Chikungunya virus in Aedes albopictus, Italy. Emerg Infect Dis 14: 852–854.
- 8. Garrett-Jones C, Shidrawi GR (1969) Malaria vectorial capacity of a population of Anopheles gambiae: an exercise in epidemiological entomology. Bull World Health Organ 40: 531–545.
- 9. Shaukat AM, Breman JG, McKenzie FE (2010) Using the entomological inoculation rate to assess the impact of vector control on malaria parasite transmission and elimination. Malar J 9: 122.
- 10. Garrett-Jones C (1964) The Human Blood Index of Malaria Vectors in Relation to Epidemiological Assessment. Bull World Health Organ 30: 241–261.
- 11. Service MW (1977) A critical review of procedures for sampling populations of adult mosquitoes. Bulletin of Entomological Research 67: 343–382.
- 12. Cano J, Berzosa PJ, Roche J, Rubio JM, Moyano E, et al. (2004) Malaria vectors in the Bioko Island (Equatorial Guinea): estimation of vector dynamics and transmission intensities. J Med Entomol 41: 158–161.
- 13. Cano J, Descalzo MA, Moreno M, Chen Z, Nzambo S, et al. (2006) Spatial variability in the density, distribution and vectorial capacity of anopheline species in a high transmission village (Equatorial Guinea). Malar J 5: 21.
- 14. Bodker R, Akida J, Shayo D, Kisinza W, Msangeni HA, et al. (2003) Relationship between altitude and intensity of malaria transmission in the Usambara Mountains, Tanzania. J Med Entomol 40: 706–717.
- 15. Mbogo CM, Mwangangi JM, Nzovu J, Gu W, Yan G, et al. (2003) Spatial and temporal heterogeneity of Anopheles mosquitoes and Plasmodium falciparum transmission along the Kenyan coast. Am J Trop Med Hyg 68: 734–742.
- 16. Orlandi-Pradines E, Rogier C, Koffi B, Jarjaval F, Bell M, et al. (2009) Major variations in malaria exposure of travellers in rural areas: an entomological cohort study in western Cote d'Ivoire. Malar J 8: 171.
- 17. Qiu YT, Smallegange RC, Van Loon JJ, Ter Braak CJ, Takken W (2006) Interindividual variation in the attractiveness of human odours to the malaria mosquito Anopheles gambiae s. s. Med Vet Entomol 20: 280–287.
- 18. Cornelie S, Remoue F, Doucoure S, Ndiaye T, Sauvage FX, et al. (2007) An insight into immunogenic salivary proteins of Anopheles gambiae in African children. Malar J 6: 75.
- 19. Nascimento RJ, Santana JM, Lozzi SP, Araujo CN, Teixeira AR (2001) Human IgG1 and IgG4: the main antibodies against Triatoma infestans (Hemiptera: Reduviidae) salivary gland proteins. Am J Trop Med Hyg 65: 219–226.
- 20. Palosuo K, Brummer-Korvenkontio H, Mikkola J, Sahi T, Reunala T (1997) Seasonal increase in human IgE and IgG4 antisaliva antibodies to Aedes mosquito bites. Int Arch Allergy Immunol 114: 367–372.
- 21. Poinsignon A, Remoue F, Rossignol M, Cornelie S, Courtin D, et al. (2008) Human IgG antibody response to Glossina saliva: an epidemiologic marker of exposure to Glossina bites. Am J Trop Med Hyg 78: 750–753.
- 22. Teixeira C, Gomes R, Collin N, Reynoso D, Jochim R, et al. (2010) Discovery of markers of exposure specific to bites of Lutzomyia longipalpis, the vector of Leishmania infantum chagasi in Latin America. PLoS Negl Trop Dis 4: e638.
- 23. Billingsley PF, Baird J, Mitchell JA, Drakeley C (2006) Immune interactions between mosquitoes and their hosts. Parasite Immunol 28: 143–153.
- 24. Ribeiro JM (1995) Blood-feeding arthropods: live syringes or invertebrate pharmacologists? Infect Agents Dis 4: 143–152.
- 25. Remoue F, Alix E, Cornelie S, Sokhna C, Cisse B, et al. (2007) IgE and IgG4 antibody responses to Aedes saliva in African children. Acta Trop 104: 108–115.
- 26. Remoue F, Cisse B, Ba F, Sokhna C, Herve JP, et al. (2006) Evaluation of the antibody response to Anopheles salivary antigens as a potential marker of risk of malaria. Trans R Soc Trop Med Hyg 100: 363–370.
- 27. Waitayakul A, Somsri S, Sattabongkot J, Looareesuwan S, Cui L, et al. (2006) Natural human humoral response to salivary gland proteins of Anopheles mosquitoes in Thailand. Acta Trop 98: 66–73.
- 28. Orlandi-Pradines E, Almeras L, Denis de Senneville L, Barbe S, Remoue F, et al. (2007) Antibody response against saliva antigens of Anopheles gambiae and Aedes aegypti in travellers in tropical Africa. Microbes Infect 9: 1454–1462.
- 29. Ribeiro JM, Seulu F, Abose T, Kidane G, Teklehaimanot A (1996) Temporal and spatial distribution of anopheline mosquitos in an Ethiopian village: implications for malaria control strategies. Bull World Health Organ 74: 299–305.
- 30. Schäfer ML (2006) Influence of landscape structure on mosquitoes (Diptera: Culicidae) and dystiscids (Coleoptera: Dystiscidae) at five spatial scales in Swedish wetlands. Wetlands 26: 57–68.
- 31. Moutailler S, Krida G, Schaffner F, Vazeille M, Failloux AB (2008) Potential vectors of Rift Valley fever virus in the Mediterranean region. Vector Borne Zoonotic Dis 8: 749–753.
- 32. Vazeille M, Jeannin C, Martin E, Schaffner F, Failloux AB (2008) Chikungunya: a risk for Mediterranean countries? Acta Trop 105: 200–202.
- 33. Chevalier V, Pepin M, Plee L, Lancelot R (2010) Rift Valley fever - a threat for Europe? Euro Surveill 15: 19506.
- 34. Bellini R, Veronesi R, Draghetti S, Carrieri M (1997) Study on the flying height of Aedes caspius and Culex pipiens females in the Po Delta area, Italy. J Am Mosq Control Assoc 13: 356–360.
- 35. Balenghien T, Carron A, Sinegre G, Bicout DJ (2010) Mosquito density forecast from flooding: population dynamics model for Aedes caspius (Pallas). Bull Entomol Res 100: 247–254.
- 36. Balenghien T, Fouque F, Sabatier P, Bicout DJ (2006) Horse-, bird-, and human-seeking behavior and seasonal abundance of mosquitoes in a West Nile virus focus of southern France. J Med Entomol 43: 936–946.
- 37. Rioux JA, Croset H, Corre JJ, Simmoneau P, Gras G (1968) Phyto-ecological basis of mosquito control: cartography of larval biotopes. Mosquito News 28: 572–582.
- 38. EID (2011) Historique de la veille et surveillance d'Aedes albopictus dans le Sud Est de la France. Entente Interdepartementale pour la Démoustication du Littoral Méditerranéen: Available: http://www.albopictus.eid-med.org/les_pages/veille_et_surveillance.htm.
- 39. Penneys NS, Nayar JK, Bernstein H, Knight JW (1988) Circulating antibody detection in human serum to mosquito salivary gland proteins by the avidin-biotin-peroxidase technique. J Am Acad Dermatol 18: 87–92.
- 40. Cancrini G, Magi M, Gabrielli S, Arispici M, Tolari F, et al. (2006) Natural vectors of dirofilariasis in rural and urban areas of the Tuscan region, central Italy. J Med Entomol 43: 574–579.
- 41. Rageau J, Mouchet J (1967) Les arthropodes hématophages de Camargue. Cah ORSTOM, sér Ent méd 5: 263–281.
- 42. Rizzo C, Ronca R, Fiorentino G, Verra F, Mangano V, et al. (2011) Humoral response to the Anopheles gambiae salivary protein gSG6: a serological indicator of exposure to Afrotropical malaria vectors. PLoS One 6: e17980.
- 43. Peng Z, Rasic N, Liu Y, Simons FE (2002) Mosquito saliva-specific IgE and IgG antibodies in 1059 blood donors. J Allergy Clin Immunol 110: 816–817.
- 44. Schwartz BS, Ford DP, Childs JE, Rothman N, Thomas RJ (1991) Anti-tick saliva antibody: a biologic marker of tick exposure that is a risk factor for Lyme disease seropositivity. Am J Epidemiol 134: 86–95.
- 45. Drame PM, Poinsignon A, Besnard P, Le Mire J, Dos-Santos MA, et al. (2010) Human antibody response to Anopheles gambiae saliva: an immuno-epidemiological biomarker to evaluate the efficacy of insecticide-treated nets in malaria vector control. Am J Trop Med Hyg 83: 115–121.
- 46. Bahnck CM, Fonseca DM (2006) Rapid assay to identify the two genetic forms of Culex (Culex) pipiens L. (Diptera: Culicidae) and hybrid populations. Am J Trop Med Hyg 75: 251–255.
- 47. Chevillon C, Raymond M, Rousset F, Smouse PE, Pasteur N (1998) Migration/selection balance and ecotypic differentiation in the mosquito Culex pipiens. Molecular Ecology 7: 197–208.
- 48. Byrne K, Nichols RA (1999) Culex pipiens in London Underground tunnels: differentiation between surface and subterranean populations. Heredity 82: 7–15.
- 49. Vinogradova EB (2003) Ecophysiological and morphological variations in mosquitoes of the Culex pipiens complex (Diptera: Culicidae). Acta Soc Zool Bohem 67: 41–50.
- 50. Mihalyi F (1965) Review of the Culex pipiens molestus Forskal problem in eastern Europe, with special reference to urbanization. WHO (Vector Control) 25: 33–39.
- 51. Brummer-Korvenkontio H, Palosuo T, Francois G, Reunala T (1997) Characterization of Aedes communis, Aedes aegypti and Anopheles stephensi mosquito saliva antigens by immunoblotting. Int Arch Allergy Immunol 112: 169–174.
- 52. Almeras L, Lefranc D, Drobecq H, de Seze J, Dubucquoi S, et al. (2004) New antigenic candidates in multiple sclerosis: identification by serological proteome analysis. Proteomics 4: 2184–2194.
- 53. Wasinpiyamongkol L, Patramool S, Luplertlop N, Surasombatpattana P, Doucoure S, et al. (2009) Blood-feeding and immunogenic Aedes aegypti saliva proteins. Proteomics 10: 1906–1916.
- 54. Fontaine A, Pophillat M, Bourdon S, Villard C, Belghazi M, et al. (2010) Specific antibody responses against membrane proteins of erythrocytes infected by Plasmodium falciparum of individuals briefly exposed to malaria. Malar J 9: 276.
- 55. Ribeiro JMC, Mans BJ, Arcà B (2010) An insight into the sialome of blood-feeding Nematocera. Insect Biochemistry and Molecular Biology 40: 767–784.
- 56. Trevejo RT, Reisen WK, Yoshimura G, Reeves WC (2005) Detection of chicken antibodies to mosquito salivary gland antigens by enzyme immunoassay. J Am Mosq Control Assoc 21: 39–48.
- 57. Wheeler CM, Coleman JL, Benach JL (1991) Salivary gland antigens of Ixodes dammini are glycoproteins that have interspecies cross-reactivity. J Parasitol 77: 965–973.
- 58. Poncon N, Balenghien T, Toty C, Baptiste Ferre J, Thomas C, et al. (2007) Effects of local anthropogenic changes on potential malaria vector Anopheles hyrcanus and West Nile virus vector Culex modestus, Camargue, France. Emerg Infect Dis 13: 1810–1815.
- 59. Poncon N, Toty C, L'Ambert G, le Goff G, Brengues C, et al. (2007) Population dynamics of pest mosquitoes and potential malaria and West Nile virus vectors in relation to climatic factors and human activities in the Camargue, France. Med Vet Entomol 21: 350–357.
- 60. Benedict MQ, Levine RS, Hawley WA, Lounibos LP (2007) Spread of the tiger: global risk of invasion by the mosquito Aedes albopictus. Vector Borne Zoonotic Dis 7: 76–85.
- 61. Rogers DJ, Wilson AJ, Hay SI, Graham AJ (2006) The global distribution of yellow fever and dengue. Adv Parasitol 62: 181–220.
- 62. Jansen CC, Beebe NW (2010) The dengue vector Aedes aegypti: what comes next. Microbes Infect 12: 272–279.
- 63. Almeras L, Fontaine A, Belghazi M, Bourdon S, Boucomont-Chapeaublanc E, et al. (2010) Salivary gland protein repertoire from Aedes aegypti mosquitoes. Vector Borne Zoonotic Dis 10: 391–402.
- 64. Fontaine A, Pascual A, Diouf I, Bakkali N, Bourdon S, et al. (2011) Mosquito salivary gland protein preservation in the field for immunological and biochemical analysis. Parasit Vectors 4: 33.
- 65. Poinsignon A, Cornelie S, Ba F, Boulanger D, Sow C, et al. (2009) Human IgG response to a salivary peptide, gSG6-P1, as a new immuno-epidemiological tool for evaluating low-level exposure to Anopheles bites. Malar J 8: 198.